News Image

BioMarin Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Guidance

Provided By PR Newswire

Last update: Feb 19, 2025

Strong Execution and Operational Transformation in 2024 Delivered Record Full Year Results and Provides Momentum for Double-Digit Revenue and Profitability Growth in 2025

Read more at prnewswire.com

BIOMARIN PHARMACEUTICAL INC

NASDAQ:BMRN (2/27/2025, 12:08:59 PM)

69.23

+0.42 (+0.61%)



Find more stocks in the Stock Screener

Follow ChartMill for more